112 related articles for article (PubMed ID: 23225289)
21. First Fracture Project: addressing the osteoporosis care gap.
Vaile J; Sullivan L; Bennett C; Bleasel J
Intern Med J; 2007 Oct; 37(10):717-20. PubMed ID: 17894768
[TBL] [Abstract][Full Text] [Related]
22. Effective chronic disease management: patients' perspectives on medication-related problems.
Gordon K; Smith F; Dhillon S
Patient Educ Couns; 2007 Mar; 65(3):407-15. PubMed ID: 17081720
[TBL] [Abstract][Full Text] [Related]
23. Patient-specific factors relating to medication adherence in a post-percutaneous coronary intervention cohort.
Rushworth GF; Cunningham S; Mort A; Rudd I; Leslie SJ
Int J Pharm Pract; 2012 Aug; 20(4):226-37. PubMed ID: 22775519
[TBL] [Abstract][Full Text] [Related]
24. Clinical strategies to address patients' concerns in osteoporosis management with bisphosphonates.
Cole RE
Postgrad Med; 2011 Mar; 123(2):131-44. PubMed ID: 21474901
[TBL] [Abstract][Full Text] [Related]
25. Osteoporosis prevention, diagnosis, and therapy.
NIH Consens Statement; 2000 Mar 27-29; 17(1):1-45. PubMed ID: 11525451
[TBL] [Abstract][Full Text] [Related]
26. Influence of patient perceptions and preferences for osteoporosis medication on adherence behavior in the Denosumab Adherence Preference Satisfaction study.
Kendler DL; Macarios D; Lillestol MJ; Moffett A; Satram-Hoang S; Huang J; Kaur P; Tang ET; Wagman RB; Horne R
Menopause; 2014 Jan; 21(1):25-32. PubMed ID: 23676636
[TBL] [Abstract][Full Text] [Related]
27. Bone health management in prostate cancer patients receiving androgen deprivation therapy.
Dhanapal V; Reeves DJ
J Oncol Pharm Pract; 2012 Mar; 18(1):84-90. PubMed ID: 21807761
[TBL] [Abstract][Full Text] [Related]
28. Factors influencing illness representations and perceived adherence in haemophilic patients: a pilot study.
Lamiani G; Strada I; Mancuso ME; Coppola A; Vegni E; Moja EA;
Haemophilia; 2015 Sep; 21(5):598-604. PubMed ID: 25684356
[TBL] [Abstract][Full Text] [Related]
29. "Why Am I Not Taking Medications?" Barriers and Facilitators of Diabetes Medication Adherence Across Different Health Literacy Levels.
Huang YM; Pecanac KE; Shiyanbola OO
Qual Health Res; 2020 Dec; 30(14):2331-2342. PubMed ID: 32723206
[TBL] [Abstract][Full Text] [Related]
30. An exploration of illness representations and treatment beliefs in heart failure.
MacInnes J
J Clin Nurs; 2014 May; 23(9-10):1249-56. PubMed ID: 23808672
[TBL] [Abstract][Full Text] [Related]
31. Barriers and facilitators of adherence to antidepressants among outpatients with major depressive disorder: A qualitative study.
Ho SC; Jacob SA; Tangiisuran B
PLoS One; 2017; 12(6):e0179290. PubMed ID: 28614368
[TBL] [Abstract][Full Text] [Related]
32. The Impact of 3-D Models versus Animations on Perceptions of Osteoporosis and Treatment Motivation: A Randomised Trial.
Jones ASK; Fernandez J; Grey A; Petrie KJ
Ann Behav Med; 2017 Dec; 51(6):899-911. PubMed ID: 28474286
[TBL] [Abstract][Full Text] [Related]
33. Use of path modeling to inform a clinical decision support application to encourage osteoporosis medication use.
Miller MJ; Jou T; Danila MI; Mudano AS; Rahn EJ; Outman RC; Saag KG
Res Social Adm Pharm; 2021 Jul; 17(7):1267-1275. PubMed ID: 33011082
[TBL] [Abstract][Full Text] [Related]
34. Reviving Research on Medication Attitudes for Improving Pharmacotherapy: Focusing on Adherence.
De Las Cuevas C; de Leon J
Psychother Psychosom; 2017; 86(2):73-79. PubMed ID: 28183085
[TBL] [Abstract][Full Text] [Related]
35. Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF).
Hiligsmann M; Cornelissen D; Vrijens B; Abrahamsen B; Al-Daghri N; Biver E; Brandi ML; Bruyère O; Burlet N; Cooper C; Cortet B; Dennison E; Diez-Perez A; Gasparik A; Grosso A; Hadji P; Halbout P; Kanis JA; Kaufman JM; Laslop A; Maggi S; Rizzoli R; Thomas T; Tuzun S; Vlaskovska M; Reginster JY
Osteoporos Int; 2019 Nov; 30(11):2155-2165. PubMed ID: 31388696
[TBL] [Abstract][Full Text] [Related]
36. [Drug prescriptions: Adherence and understanding in Madagascar].
Raharinjatovo L; Ralandison S
Med Sante Trop; 2015; 25(1):82-6. PubMed ID: 25787855
[TBL] [Abstract][Full Text] [Related]
37. Medication adherence Part three: Strategies for improving adherence.
Roberts ME; Wheeler KJ; Neiheisel MB
J Am Assoc Nurse Pract; 2014 May; 26(5):281-7. PubMed ID: 24616472
[TBL] [Abstract][Full Text] [Related]
38. Understanding Physicians' Perceptions of Patient-Identified Barriers to Osteoporosis Medication Initiation: A Cognitive Mapping Approach.
Qu H; Silverman SL; Shewchuk RM; Curtis JR; Austin S; Greenspan SL; Nieves JW; Outman RC; Warriner AH; Watts NB; Saag KG
Risk Manag Healthc Policy; 2022; 15():1293-1302. PubMed ID: 35818434
[TBL] [Abstract][Full Text] [Related]
39. Risk, significance and biomedicalisation of a new population: older women's experience of osteoporosis screening.
Salter CI; Howe A; McDaid L; Blacklock J; Lenaghan E; Shepstone L
Soc Sci Med; 2011 Sep; 73(6):808-15. PubMed ID: 21813219
[TBL] [Abstract][Full Text] [Related]
40. Patient and Caregiver Priorities for Medication Adherence in Gout, Osteoporosis, and Rheumatoid Arthritis: Nominal Group Technique.
Kelly A; Tymms K; de Wit M; Bartlett SJ; Cross M; Dawson T; De Vera M; Evans V; Gill M; Hassett G; Lim I; Manera K; Major G; March L; O'Neill S; Scholte-Voshaar M; Sinnathurai P; Sumpton D; Teixeira-Pinto A; Tugwell P; van den Bemt B; Tong A
Arthritis Care Res (Hoboken); 2020 Oct; 72(10):1410-1419. PubMed ID: 31325214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
